Your browser doesn't support javascript.
loading
Protein Corona Composition of Gold Nanocatalysts.
Ashkarran, Ali Akbar; Tadjiki, Soheyl; Lin, Zijin; Hilsen, Kylie; Ghazali, Noor; Krikor, Sarah; Sharifi, Shahriar; Asgari, Meisam; Hotchkin, Michael; Dorfman, Adam; Ho, Karen S; Mahmoudi, Morteza.
Afiliación
  • Ashkarran AA; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, Michigan 48824, United States.
  • Tadjiki S; Postnova Analytics Inc., Salt Lake City, Utah 84102, United States.
  • Lin Z; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, Michigan 48824, United States.
  • Hilsen K; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, Michigan 48824, United States.
  • Ghazali N; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, Michigan 48824, United States.
  • Krikor S; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, Michigan 48824, United States.
  • Sharifi S; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, Michigan 48824, United States.
  • Asgari M; Department of Medical Engineering, University of South Florida, Tampa, Florida 33620, United States.
  • Hotchkin M; Clene Nanomedicine, Inc., Salt Lake City, Utah 84121, United States.
  • Dorfman A; Clene Nanomedicine, Inc., Salt Lake City, Utah 84121, United States.
  • Ho KS; Clene Nanomedicine, Inc., Salt Lake City, Utah 84121, United States.
  • Mahmoudi M; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, Michigan 48824, United States.
ACS Pharmacol Transl Sci ; 7(4): 1169-1177, 2024 Apr 12.
Article en En | MEDLINE | ID: mdl-38633595
ABSTRACT
The interaction between nanoparticles (NPs) and biological environments is profoundly influenced by a stable, strongly adsorbed "hard" protein corona. This corona significantly determines the NPs' pharmacokinetics and biological destiny. Our study delves into the mechanisms by which colloidal Au nanocrystals that are synthesized electrochemically without surface-capping organic ligands, known as CNM-Au8, traverse the blood-brain barrier (BBB) and target human brain tissue for treating neurodegenerative disorders. We discovered that upon interaction with human plasma, CNM-Au8 gold nanocrystals (AuNCs) effectively attract a variety of crucial apolipoproteins, notably apolipoproteins E, to their surfaces. This interaction likely facilitates their passage through the BBB. Furthermore, the coronas of these AuNCs exhibit a substantial presence of albumin and a notable absence of opsonin-based proteins, contributing to prolonged blood circulation. These characteristics align well with the clinical performance observed for the CNM-Au8 NCs. This study highlights that AuNCs with intentionally engineered structures and surfactant-free surfaces can create a distinct protein corona composition. This finding holds significant promise for the development of advanced therapeutic agents aimed at combating neurodegenerative diseases.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Pharmacol Transl Sci Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Pharmacol Transl Sci Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos